30Jun
Healthcare M&A prospers, despite fall in deal activity
The megadeals of 2019 may be off the table for now, but deal activity across healthcare and pharmaceuticals has proven resilient through the COVID-19 crisis - Although pharma, medical and biotech (PMB) M&A deal value for Q1 2020 came in at US$39.3 billion, 78% below the year before, this was primarily due to the outsized US$87.8 billion deal between Bristol-Myers Squibb and Celgene in early 2019....
By:
White & Case LLP
Related
Seyfarth Synopsis: Cal/OSHA’s new emergency regulation for workers exposed to wildfire smoke create...
Read More >
Here's how to keep it under control. A very large national employer (you've probably heard of it --...
Read More >
On August 5, 2020, the Seminole County Planning and Zoning Commission unanimously voted to table the...
Read More >
The U.S. Citizenship and Immigration Service (“USCIS”) recently announced it has adopted an admini...
Read More >
The DE OFCCP Week in Review (WIR) is a simple, fast and direct summary of relevant happenings in the...
Read More >
With its glamorous brand, address, association with and access to an adjoining luxury hotel, a well-...
Read More >